CIK 0001048477
- Large accelerated filer
BIOMARIN PHARMACEUTICAL INC
Sign in to watch- Ticker
- BMRN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 680397820
- Phone
- +1 415-506-6700
- Business address
- 105 DIGITAL DRIVE, NOVATO, CA, 94949
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $1,163,748
- in 1 filing
Net −$1,163,748. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-03-17 | Mueller Brian EVP, Chief Financial Officer | Shares withheld for taxes | −2,117 | $56.05 | $119K | 123,314 |
| 2026-03-16 | Mueller Brian EVP, Chief Financial Officer | Grant or award | +18,740 | 125,431 | ||
| 2026-03-16 | Mueller Brian EVP, Chief Financial Officer | Grant or award · Stock Option (Right to Buy Common Stock) | +44,600 | 44,600 | ||
| 2026-03-13 | Mueller Brian EVP, Chief Financial Officer | Shares withheld for taxes | −9,945 | $58.51 | $582K | 106,691 |
| 2026-02-25 | Mueller Brian EVP, Chief Financial Officer | Grant or award | +6,683 | 106,839 | ||
| 2026-02-25 | Mueller Brian EVP, Chief Financial Officer | Grant or award | +7,230 | 114,069 | ||
| 2026-02-25 | Mueller Brian EVP, Chief Financial Officer | Grant or award | +2,569 | 116,638 | ||
| 2025-03-17 | Mueller Brian EVP, Chief Financial Officer | Grant or award | +16,640 | 99,781 | ||
| 2025-03-17 | Mueller Brian EVP, Chief Financial Officer | Grant or award · Stock Option (Right to Buy Common Stock) | +38,590 | 38,590 | ||
| 2025-03-14 | Mueller Brian EVP, Chief Financial Officer | Shares withheld for taxes | −18,497 | $69.44 | $1.3M | 83,141 |
| 2025-02-25 | Mueller Brian EVP, Chief Financial Officer | Grant or award | +11,040 | 82,611 | ||
| 2025-02-25 | Mueller Brian EVP, Chief Financial Officer | Grant or award | +9,660 | 92,271 | ||
| 2025-02-25 | Mueller Brian EVP, Chief Financial Officer | Grant or award | +9,367 | 101,638 | ||
| 2024-06-28 | Mueller Brian EVP, Chief Financial Officer | Shares withheld for taxes | −588 | $82.33 | $48K | 71,571 |
| 2024-05-30 | Mueller Brian EVP, Chief Financial Officer | Exercise or conversion 10b5-1 | +5,000 | $63.10 | $316K | 77,159 |
| 2024-05-30 | Mueller Brian EVP, Chief Financial Officer | Sale 10b5-1 | −5,000 | $75.19 | $376K | 72,159 |
| 2024-05-30 | Mueller Brian EVP, Chief Financial Officer | Exercise or conversion · Stock Option (Right to Buy Common Stock) 10b5-1 | −5,000 | 0 | ||
| 2024-04-30 | Mueller Brian EVP, Chief Financial Officer | Grant or award 10b5-1 | +300 | $68.65 | $21K | 72,159 |
| 2024-03-15 | Mueller Brian EVP, Chief Financial Officer | Grant or award | +11,400 | 92,648 | ||
| 2024-03-15 | Mueller Brian EVP, Chief Financial Officer | Shares withheld for taxes | −20,789 | $83.87 | $1.7M | 71,859 |
Page 1 of 4 · 64 trades